Stocks360

Invacare Corporation (IVC)

Stock analysis · NYSE · Healthcare · Medical - Instruments & Supplies

Share: Facebook X WhatsApp SMS
$0.66

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$24.91M
PE (TTM)
-0.24
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
0.00
Day Range
$0.66 – $0.70
52-wk Range
$0.02 – $2.53
Avg Volume
N/A
Volume
0.00

Invacare Corporation (IVC) is a publicly traded company in the Healthcare sector. Latest price: $0.66. Market cap $24.91M. Trailing PE -0.24. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
May 8, 2023
EPS $-1.08 vs est. $-0.55
Missed by $0.53

Proprietary Signals

Signal snapshot temporarily unavailable.

About Invacare Corporation

Invacare Corporation, along with its affiliated entities, stands as a prominent international provider specializing in the design, production, distribution, and global export of medical devices. These products cater to diverse sectors, including home healthcare, retail environments, and long-term care facilities worldwide. Its extensive product portfolio encompasses mobility and seating solutions. These include power wheelchairs sold under the Invacare TDX brand, custom manual wheelchairs bearing the Invacare, Invacare Top End, and Küschall names, and various seating and positioning aids within the Invacare line. Furthermore, specialized custom molded seat modules are offered under the PinDot brand. Beyond mobility, Invacare supplies a range of daily living aids. This category features pressure-relieving overlays and mattress systems, such as the Invacare Softform and microAIR series; safe patient handling equipment like the Birdie, Evo, and ISA brands; and residential and institutional care beds along with their accessories, and certain manual wheelchairs, all primarily under the Invacare label. The company also provides personal care items. Additionally, the firm is a key suppli…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-0.24×
P/S (TTM)0.03×
P/B0.30×
PEG0.00×
P/FCF (TTM)-0.42×
EV / EBITDA-9.01×
EV / Sales0.60×
Earnings Yield-419.49%
Free Cash Flow Yield-236.97%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$442.54M
Revenue (TTM)$741.73M
Net Income (TTM)-$104.50M
Free Cash Flow (TTM)-$29.62M
Net Debt$417.63M
Working Capital$79.18M
Gross Margin23.65%
Operating Margin-9.37%
Net Margin-13.63%
Return on Equity-46.11%
Return on Invested Capital-12.54%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap